Member Info for sageofclapham

Or alternatively they have a plan …

No directors buying … (inside on a deal?)

Long lead time to AGM post report and accounts … when directors are re elected … giving time to get a deal done ..

Hedgies have to close 30m declared if not double that so 60m …

I suspect something going on that might create a big positive surprise

Was looking at who the owners of Superdrug was and I didn’t realise it is Asian owned by AS Watson - not a name I know well but they have 17,000 health and beauty shops in Asia and clearly a London presence. Ultimate owner is Hutchison Hong Kong listed at £15bn ish value. AS Watson appear to be the only other health and beauty company of any size combined like THG … don’t know how good AS Watson is online but a combination of Superdrug and Lookfantastic and Cult you would think makes sense especially if Asian companies want to do more in Europe now post Trumps antics - does anyone know AS Watson / Superdrug ?

Sunday Times today in the business section has the great Lord proposed as ‘NED of the year’ for his efforts for THG ! I can’t copy the article but it is out today perhaps someone else can - ‘Shortlist revealed..’ is the title - business section Sunday Times. I did have to check the title of his award …. I cannot think what the criteria is for such an award .. am sure we will all be voting …

This is really helpful thx Cratfy investor

Dr Lao … Moulding is almost certainly already paying him !! Not company sponsored or anything ..! That’s a good thing as it means they are serious

Maybe even Kelso are giving up with Mr Mouldings inability to listen - don’t blame them

Sorry what did Oliver Cookson say ? I missed it

Reading now - sorry don’t know how to paste content

That is Qube pushing it down to then pick up stock lower down - problem is there wasn’t any stock to pick up

They are still 7m short with 4 trading days to go

They will def be closing that ahead of the results

Guys and gals

It’s a sh it US market, we have v thin vols - we just need to su ck it up and be patient - painful but that is the realisty

We have something many many big co’s want at massively higher multiples - we need to dangle that carrot

Hang tough !!

Just googled news on STJ - fairly easy to find is a comment from post the last results from Numis analyst which says ‘the fee change maybe just the top of the ice berg’ - being the revised charges going forward - def more credibility than my view

Global domination !!…

There was def a buyer late pm today

6 trading days left ..

Re 44-47 - the recovery will be based on all metrics being constantly beaten for several announcement dates - including interims

Correct, anyone who has done the numbers of whey input and cost out etc knows 44-47 is wrong and £120m FY is wrong. I am talking real numbers without provisions / profits tucked away which is all we will see H1

They should be decently be above all those numbers

The Good Lord will ensure that until the year is nailed and in the bag we won’t get the bigger uplift - but small beats in the interim until they are ready for the big one - Jan 17 ‘24

All in my humble opinion. I won’t repeat the numbers. I have said them many times. I expect ebitda £150/160m current year maybe more

They need to do three things - beat numbers, beat numbers and beat numbers - simple. Interesting Jan 17th year end update has been in the IR public calendar for some time ..!

Mats front footed rhetoric is telling you something … he is relaxed

Patience

Although the FT piece at the weekend is pretty damning - it is the hundreds of comments within the FT about the piece and their views on this company which are worse and give the issue even more credence

My estimate is we slip to 400p. 20% profit cut and the balance a reduced rating as the issues play out

Hope this is a board that accepts two way views….

Just kicked off my holding with a sell

I have followed this stock a while, in an era of zero interest rates using an STJ to come up with some clever structurings might have had a place in life even if an investor could stomach the fees BUT in a world where a cash investor can get 5% min falling off a log STJ’s raison d’etre is far reduced.

Throw in a proper stewards (at last!) about their clever charging structures … newish blood for the journos who won’t give up now on the subject

I am not into general shorting but where it is companies like STJ then it is game on who have charged many many grannies the wrong fees for many years it is fair game. This is one of those straight to the bottom line profit reductions when revenue drops …

Throw in some shocking fund performances … the current rating could soon look extremely expensive and the viscous circle will begin compounded by trackers reducing as the market cap shrinks

Role on Oct 18 next news

Hopefully that and a bit more !!

I just hope they tell us all about the breadth of the new MP products and the seriously widened routes to market with all the new retail relationships

Including today 8 trading days left

Agreed !

Reckon today was the last day sub 100p post nasdaq finishing well

We should get the interims date soon which will sound the starting gun for a rally - hoping Sept 15th ish - earlier that week would be even better - no drama if early the week after

The end of year trading statement is already set for Jan 17th in the financial calendar - that is when we hope to get the proper upgrade / beat and 150p + .. no parcel delivery delays this year unlike last year hopefully which is why best for them to wait till then with the bigger news

Probably no more than 25/ 30m shares to trade pre the interims pop 🤞

Very exciting with the explosion of new products that must be driven by demand

At 90p we are around £1.15bn mkt cap I think

Ebitda current year £120m going to £160m next year - I believe ebitda current year will end up being north of £150m… we will get a better flavour in two weeks …

On any metric that should be £2bn

Still on 0.5x to sales ratio which is bonkers

On any metric sit tight and wait for mid Sept ..

Agree Mr Ephemerel - let the numbers do the talking - beat beat beat - £50m ebitda out of £120m H1 when the big benefit is in H2 care of whey and cost savings - min £150m full year - line in the sand - more next year